Tulane Home Tulane Shield logo linking to site home page

Tulane School of Medicine News

 

 

Amber Hardeman 3
Tulane researchers find many COVID-19 vaccination plans lacked strategies for equitable rollout
A new research letter published in JAMA Network Open examined the COVID-19 vaccine distribution plans for all 50 states and the District of Columbia. The study found a majority of the vaccine rollout plans lacked diverse representation on the state health committees, along with strategies to reach...

Tulane School of Medicine News

COVID-19 Digest focuses on delta variant - Aug 09, 2021
This is a special issue of the Tulane COVID-19 Digest. As the delta variant fuels a fourth surge in the US among unvaccinated individuals, media reports of breakthrough infections are receiving increasing attention. While breakthroughs can happen, the overwhelming (90%+) majority of new infections, hospitalizations and deaths are among not completely vaccinated individuals. This unvaccinated population is the primary driver of the current surge...
Study by Tulane researcher suggests marijuana can cause infertility in men - Aug 09, 2021
As more states legalize marijuana, a new study by a Tulane University researcher has a warning for would-be dads. Smoking weed regularly may harm a man’s fertility. Researchers from Tulane and the University of Washington found a connection between low semen volume and damaged sperm among men who smoked marijuana. But the side effects weren’t all bad. The study also found that men who smoked marijuana were more likely to have sperm that swam...
Tulane researchers design nanotechnology blood test to find hidden COVID-19 infections - Aug 05, 2021
Nasal swab PCR tests are the gold standard for diagnosing COVID-19. But sometimes these tests miss cases when patients are swabbed later in the course of their infection as viral levels decline in the upper respiratory tract yet remain in the lungs, gut or other parts of the body. Tulane University researchers have developed a new type of blood test to find these hidden infections using nanoparticles to detect fragments of the virus released by...
Fourth-year student named to Board of Directors of Southern Medical Association - Jul 30, 2021
Natalie Weiss wanted to stay up-to-date with the latest recent advancements in medicine and network with other like-minded people in the field, so the fourth-year student at Tulane University School of Medicine got involved with the Southern Medical Association (SMA). She applied for a position on the education committee and helped launch a working group specifically geared to physicians-in-training. Those efforts led to Weiss being appointed to...
Promotions and changes in School of Medicine leadership - Jul 28, 2021
The School of Medicine is pleased to announce several important changes and promotions with the SoM leadership: Paul Gladden, MD, Associate Professor of OrthopaedicsPromoted to DIO and Associate Dean for GMEDirector, Residency and Orthopaedic Trauma Service and Surgery at UMCNO, Surgeon, The United States Marshals and The New Orleans Police Department. Dr. Gladden joined Tulane School of Medicine, Department of Orthopaedics as Associate...
Tulane launches ‘biobank’ for researchers studying causes of long COVID-19 - Jul 28, 2021
For most people, a mild case of COVID-19 lasts less than two weeks. But some COVID-19 “long-haulers” face a range of symptoms — dizziness, brain fog, headaches and loss of their sense of smell — that can linger for months. Researchers can’t explain exactly why. Tulane University has launched a new COVID-19 “biobank” of blood and cell samples from COVID-19 survivors to help researchers investigate what causes some to recover quickly from the...
Tulane University, Children’s Hospital launch Moderna Covid-19 vaccine trial for children from 6 months to 11 years old - Jul 21, 2021
Tulane University School of Medicine and Children’s Hospital New Orleans are participating in a national clinical trial to test the effectiveness of Moderna’s COVID-19 vaccine in children ages six months to 11 years old. The KidCOVE Study plans to enroll children across the country to test how the vaccine may protect young children from getting sick if they come into contact with SARS-CoV-2, the virus that causes COVID-19. Portions of the trial...
New fellowship focused on maternal health seeks applicants - Jul 19, 2021
Tulane University School of Medicine has received a $1.4 million grant from the Health Resources and Services Administration to support education and research of maternal health in Louisiana. It funds a two-year fellowships in Preventive Medicine focused on improving maternal health in the state and is open to anyone who has graduated from a pediatric, family medicine or internal medicine residency.  Louisiana has one of the highest maternal...
Tulane University rolls out graduate certificate in sports medicine - Jul 14, 2021
The Tulane School of Professional Advancement (SoPA) now offers a graduate certificate in Sports Medicine in partnership with the Tulane School of Medicine and the Center for Sport. The certificate program will begin in summer 2021, and enrollment is open.  “We are very excited to add this stackable certificate to the master’s program. This is a first-of-its-kind program to help non-medical sports professionals understand the breadth of the...
Tulane researcher one of two across the globe named Gilead Sciences Research Scholar - Jul 13, 2021
Only two researchers in the world will be named a Gilead Sciences Research Scholar in Cystic Fibrosis, and one is Tulane University’s own assistant professor of medicine Christine Bojanowski, MD. The program recognizes and supports emerging investigators in several medical fields including hematological malignancies, solid tumors, HIV, liver disease, and anti-fungal research in addition to Cystic Fibrosis (CF).  Under this award, Dr. Bojanowski...
Tulane researchers find many COVID-19 vaccination plans lacked strategies for equitable rollout - Jul 06, 2021
A new research letter published in JAMA Network Open examined the COVID-19 vaccine distribution plans for all 50 states and the District of Columbia. The study found a majority of the vaccine rollout plans lacked diverse representation on the state health committees, along with strategies to reach people living in underserved communities. Amber Hardeman, MD, MPH, MBA, a resident in the Med-Peds program at Tulane University School of Medicine,...
Tulane University’s Dr. Greg Stewart selected for Jimmy Collins Award - Jun 30, 2021
  Tulane University’s Dr. Greg Stewart, the W. Kennon McWilliams Professor of Sports Medicine in Orthopaedics, a crucial authority in keeping sports on track throughout the COVID-19 pandemic, has been selected to receive a Jimmy Collins Award from the Greater New Orleans Sports Awards Committee, sponsored by the Allstate Sugar Bowl. While there are many different categories of awards presented by the Greater New Orleans Sports Awards Committee,...
Tulane-led study published in NEJM finds new treatment for aggressive prostate cancer - Jun 29, 2021
A new cancer treatment is offering hope to patients with late-stage prostate cancer, and the results are now published in the New England Journal of Medicine (NEJM). Dr. Oliver Sartor, medical oncologist and C. E. and Bernadine Laborde Professor of Cancer Research at Tulane University School of Medicine, is lead author of the study, which used engineered radioactive molecules to target prostate cancer cells and inhibit tumor growth. The...
Tulane to launch multicenter drug study to improve outcomes after atrial fibrillation procedures - Jun 09, 2021
Tulane University will lead a multicenter clinical trial to study whether atrial fibrillation (AFib) patients who undergo cardiac ablation to correct an irregular heart rhythm have better long-term outcomes when taking an anti-arrhythmic drug. The trial will explore whether the drug Dronedarone helps decrease the scarring of the heart associated with the development of AFib and a common cause of its reoccurrence after treatment. It will also...
Molecularly targeted radiation therapy extends survival for patients with advanced prostate cancer - Jun 03, 2021
A new cancer treatment that uses engineered radioactive molecules to target prostate cancer cells and inhibit tumor growth extended survival for patients with advanced prostate cancer, according to newly announced results of the VISION trial. The international phase III clinical trial, which was co-led by Tulane University medical oncologist Dr. Oliver Sartor, is the first to use this approach to demonstrate improvements in survival for prostate...